{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:47:05Z","timestamp":1787662025936,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,30]],"date-time":"2027-01-30T00:00:00Z","timestamp":1801267200000},"content-version":"am","delay-in-days":335,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K11632"],"award-info":[{"award-number":["25K11632"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K08513"],"award-info":[{"award-number":["22K08513"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017682","name":"Japanese Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017682","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24ck0106943h0001"],"award-info":[{"award-number":["24ck0106943h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bbrc.2026.153287","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:19:32Z","timestamp":1769098772000},"page":"153287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Multistep molecular trajectory of monocytic myeloid-derived suppressor cell induction by diffuse large B-cell lymphoma cells"],"prefix":"10.1016","volume":"804","author":[{"given":"Yu","family":"Inoue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9309-7902","authenticated-orcid":false,"given":"Yuji","family":"Shimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Niiyama-Uchibori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Chinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruya","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7817-093X","authenticated-orcid":false,"given":"Takahiro","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6803-5491","authenticated-orcid":false,"given":"Taku","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6498-1755","authenticated-orcid":false,"given":"Shinsuke","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6130-1550","authenticated-orcid":false,"given":"Junya","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153287_bib1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse large B-Cell lymphoma","volume":"384","author":"Sehn","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.153287_bib2","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/bjh.19860","article-title":"Sequencing of therapy for patients with diffuse large B-cell lymphoma in the era of novel drugs","volume":"205","author":"Karsten","year":"2024","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbrc.2026.153287_bib3","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.153287_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1804980","article-title":"Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma","volume":"380","author":"Schuster","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.153287_bib5","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(20)31366-0","article-title":"Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study","volume":"396","author":"Abramson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2026.153287_bib6","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1200\/JCO.22.01725","article-title":"Epcoritamab, a novel subcutaneous CD3\u00d7CD20 bispecific T-cell-engaging antibody, in relapsed or refractory large B-cell lymphoma: dose expansion in a phase I\/II trial","volume":"41","author":"Thieblemont","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.153287_bib7","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/cells13121057","article-title":"Tumour microenvironment: the general principles of pathogenesis and implications in diffuse large B cell lymphoma","volume":"13","author":"Sinkarevs","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.153287_bib8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3389\/fimmu.2018.00398","article-title":"Targeting myeloid-derived suppressor cells to bypass tumor-induced immunosuppression","volume":"9","author":"Fleming","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153287_bib9","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3389\/fimmu.2020.01680","article-title":"The new era of cancer immunotherapy: targeting myeloid-derived suppressor cells to overcome immune evasion","volume":"11","author":"De Cicco","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153287_bib10","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2010-05-283820","article-title":"Immunosuppressive CD14+HLA-DRlow\/- monocytes in B-cell Non-Hodgkin lymphoma","volume":"117","author":"Lin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2026.153287_bib11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/ijlh.12203","article-title":"CD14+HLA-DRlow\/- monocytes as indicator of disease aggressiveness in B-cell Non-Hodgkin lymphoma","volume":"36","author":"Khalifa","year":"2014","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.bbrc.2026.153287_bib12","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1182\/blood.2020007445","article-title":"Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma","volume":"137","author":"Jain","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2026.153287_bib13","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjh.16881","article-title":"Lenalidomide and pomalidomide potently interfere with induction of myeloid-derived suppressor cells in multiple myeloma","volume":"191","author":"Kuwahara-Ota","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbrc.2026.153287_bib14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/bjh.19049","article-title":"Tumour-derived exosomes promote the induction of monocytic myeloid-derived suppressor cells from peripheral blood mononuclear cells by delivering miR-106a-5p and miR-146a-5p in multiple myeloma","volume":"203","author":"Mizuhara","year":"2023","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbrc.2026.153287_bib15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.exphem.2011.05.002","article-title":"Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bcl-2 and c-Myc overexpression","volume":"39","author":"Sasaki","year":"2011","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bbrc.2026.153287_bib16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/1097-0142(19880201)61:3<483::AID-CNCR2820610313>3.0.CO;2-L","article-title":"Characterization and comparison of two newly established Epstein\u2013Barr virus-negative lymphoma B-cell lines: surface markers, growth characteristics, cytogenetics, and transplantability","volume":"61","author":"Abe","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2026.153287_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153287_bib18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00262-019-02302-2","article-title":"Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates","volume":"68","author":"Cassetta","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbrc.2026.153287_bib19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbrc.2026.153287_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.609948","article-title":"MIF-dependent control of tumor immunity","volume":"11","author":"Noe","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153287_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cellsig.2019.01.006","article-title":"Evolving complexity of MIF signaling","volume":"57","author":"Jankauskas","year":"2019","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbrc.2026.153287_bib22","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.4049\/jimmunol.1201161","article-title":"Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment","volume":"189","author":"Simpson","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2026.153287_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1158\/2326-6066.CIR-15-0070-T","article-title":"MIF is necessary for late-stage melanoma patient MDSC immune suppression and differentiation","volume":"4","author":"Yaddanapudi","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbrc.2026.153287_bib24","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00262-016-1896-4","article-title":"Macrophage migration inhibitory factor (MIF) is induced by cytotoxic drugs and is involved in immune escape and migration in childhood rhabdomyosarcoma","volume":"65","author":"Johler","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbrc.2026.153287_bib25","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/stem.2393","article-title":"Cancer stem cell-secreted macrophage migration inhibitory factor stimulates myeloid-derived suppressor cell function and facilitates glioblastoma immune evasion","volume":"34","author":"Otvos","year":"2016","journal-title":"Stem Cell."},{"key":"10.1016\/j.bbrc.2026.153287_bib26","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.4049\/jimmunol.1102152","article-title":"Role of macrophage migration inhibitory factor in the regulatory T cell response of tumor-bearing mice","volume":"189","author":"Choi","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2026.153287_bib27","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.4049\/jimmunol.1201650","article-title":"Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor","volume":"190","author":"Yaddanapudi","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2026.153287_bib28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/qjmed\/hcy163","article-title":"Oral squamous carcinoma cells promote macrophage polarization in an MIF-dependent manner","volume":"111","author":"De Souza Rizzo","year":"2018","journal-title":"QJM"},{"key":"10.1016\/j.bbrc.2026.153287_bib29","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1182\/blood.2020005795","article-title":"MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma","volume":"136","author":"Wang","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2026.153287_bib30","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/cncr.20818","article-title":"Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma","volume":"103","author":"Hira","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2026.153287_bib31","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1002\/cncr.24609","article-title":"Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer","volume":"115","author":"Xia","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2026.153287_bib32","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3390\/cancers16091773","article-title":"MIF and CD74 as emerging biomarkers for immune checkpoint blockade therapy","volume":"16","author":"Fey","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.153287_bib33","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1846915","article-title":"MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma","volume":"9","author":"de Azevedo","year":"2020","journal-title":"OncoImmunology"},{"key":"10.1016\/j.bbrc.2026.153287_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1161067","article-title":"The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions","volume":"14","author":"Carlini","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153287_bib35","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190418","article-title":"Biology and therapeutic potential of interleukin-10","volume":"217","author":"Saraiva","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2026.153287_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.56","article-title":"IL-10 induces the development of immunosuppressive CD14+HLA-DRlow\/- monocytes in B-cell Non-Hodgkin lymphoma","volume":"5","author":"Xiu","year":"2015","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.bbrc.2026.153287_bib37","doi-asserted-by":"crossref","first-page":"76843","DOI":"10.18632\/oncotarget.20164","article-title":"Ascites-derived IL-6 and IL-10 synergistically expand CD14+HLA-DR-\/low myeloid-derived suppressor cells in ovarian cancer patients","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2026.153287_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/17534259231172079","article-title":"Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients","volume":"29","author":"Mirja\u010di\u0107 Martinovi\u0107","year":"2023","journal-title":"Innate Immun."},{"key":"10.1016\/j.bbrc.2026.153287_bib39","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3892\/mco.2013.170","article-title":"Immunosuppression involving increased myeloid-derived suppressor cell levels, systemic inflammation and hypoalbuminemia are present in patients with anaplastic thyroid cancer","volume":"1","author":"Suzuki","year":"2013","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.153287_bib40","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1182\/blood-2011-10-388538","article-title":"Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation","volume":"119","author":"Gupta","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2026.153287_bib41","article-title":"Serum IL-10 predicts worse outcome in cancer patients: a meta-analysis","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.153287_bib42","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/bjc.2016.11","article-title":"High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma","volume":"114","author":"Wang","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2026.153287_bib43","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/s41375-024-02391-8","article-title":"IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma","volume":"38","author":"Sun","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2026.153287_bib44","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3892\/mmr.2013.1817","article-title":"Effects of recombinant human interleukin-10 on Treg cells, IL-10 and TGF-\u03b2 in transplantation of rabbit skin","volume":"9","author":"Liu","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2026.153287_bib45","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1189\/jlb.0705358","article-title":"Interleukin-10 and the immune response against cancer: a counterpoint","volume":"78","author":"Mocellin","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbrc.2026.153287_bib46","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200111","article-title":"Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine","volume":"10","author":"Yaseen","year":"2020","journal-title":"Open Biol."},{"key":"10.1016\/j.bbrc.2026.153287_bib47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/gutjnl-2021-325808","article-title":"Blockade of interleukin-10 potentiates antitumour immune function in human colorectal cancer liver metastases","volume":"72","author":"Sullivan","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2026.153287_bib48","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.2147\/CMAR.S198886","article-title":"Exosomal miRNA-107 induces myeloid-derived suppressor cell expansion in gastric cancer","volume":"11","author":"Ren","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bbrc.2026.153287_bib49","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2026.153287_bib50","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1172\/JCI80005","article-title":"Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected","volume":"125","author":"Marvel","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2026.153287_bib51","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1189\/jlb.4RI0515-204R","article-title":"Transcriptional regulation of myeloid-derived suppressor cells","volume":"98","author":"Condamine","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbrc.2026.153287_bib52","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1189\/jlb.1A0215-068RR","article-title":"Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function","volume":"100","author":"Nam","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbrc.2026.153287_bib53","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1038\/onc.2016.448","article-title":"IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer","volume":"36","author":"Yang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.153287_bib54","article-title":"Overcoming myeloid-driven resistance to CAR T therapy by targeting SPP1","author":"Gholamin","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.bbrc.2026.153287_bib55","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/onc.2016.273","article-title":"Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells","volume":"36","author":"Deng","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.153287_bib56","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2021.06.009","article-title":"Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6\/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma","volume":"518","author":"Zhao","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.153287_bib57","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/jid.2011.416","article-title":"Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas","volume":"132","author":"Fujimura","year":"2012","journal-title":"J. Invest. Dermatol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26000501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26000501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:52:45Z","timestamp":1773985965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26000501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":57,"alternative-id":["S0006291X26000501"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153287","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multistep molecular trajectory of monocytic myeloid-derived suppressor cell induction by diffuse large B-cell lymphoma cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153287"}}